scholarly journals News in immunomodulatory treatment with bacterial lysates in allergy and asthma

2019 ◽  
Vol 21 (4) ◽  
pp. 217-222
Author(s):  
Jaromír Bystroň
1998 ◽  
Vol 78 (2) ◽  
pp. 194-194
Author(s):  
D. PAYNE
Keyword(s):  

1998 ◽  
Vol 78 (5) ◽  
pp. 488-496 ◽  
Author(s):  
G G Anderson ◽  
J F J Morrison

Diagnosis ◽  
2020 ◽  
Vol 7 (4) ◽  
pp. 385-386 ◽  
Author(s):  
Jens Vikse ◽  
Giuseppe Lippi ◽  
Brandon Michael Henry

AbstractCoronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), shares similarities with the former SARS outbreak, which was caused by SARS-CoV-1. SARS was characterized by severe lung injury due to virus-induced cytopathic effects and dysregulated hyperinflammatory state. COVID-19 has a higher mortality rate in men both inside and outside China. In this opinion paper, we describe how sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression may explain the increased severity and mortality of COVID-19 in males. We highlight that immunomodulatory treatment must be tailored to the underlying immunobiology at different stages of disease. Moreover, by investigating sex-based immunobiological differences, we may enhance our understanding of COVID-19 pathophysiology and facilitate improved immunomodulatory strategies.


2013 ◽  
Vol 108 (2) ◽  
pp. 105-111 ◽  
Author(s):  
L. M. Soares ◽  
J. O. Macedo ◽  
E. C. de Azevedo ◽  
C. S. Santos ◽  
M. d. Q. Sampaio ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document